<DOC>
	<DOC>NCT02724267</DOC>
	<brief_summary>The aim of this study is to evaluate the 131I-chTNT-1/B treatment effect and safety of individual therapy using randomized controlled study, in order to acquire the evidence of evidence-based medicine and create a new program of targeted internal radiation therapy in advanced HCC patients.</brief_summary>
	<brief_title>Targeted Internal Radiation Therapy in Advanced HCC Patients.</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma, Hepatocellular</mesh_term>
	<criteria>1. Via clinical diagnosis and confirm it is advanced hepatocellular carcinoma 2. mRECIST estimation: necrosis region in HCC 3. Negative iodine allergy test 4. Liver function ：ChildPugh A/B 1. reject to attend； 2. impossible to come to our hospital for physical examination regularly. 3. Blood clotting function hindrance; 4, Patients with apparent cardiac, pulmonary, cerebral and renal dysfunction,which may affect the treatment of liver cancer.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>131I-chTNT-1/B treatment</keyword>
</DOC>